BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
BrainCells Gets $8M In First Part Of Committed $17.7M Series A
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.